ArticleStatistics in medicine2018
Pathway aggregation for survival prediction via multiple kernel learning.
Article in Statistics in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Multi-marker testing based on accelerated failure time models under possible left truncation and competing risks.Briefings in bioinformatics · 2026Article
- Survival parametric modeling for patients with heart failure based on Kernel learning.BMC medical research methodology · 2025Article
- Inference and diagnostics for censored linear regression model with skewed generalizedJournal of applied statistics · 2025Article
- Benign breast tumors may arise on different immunological backgrounds.Molecular oncology · 2024Article
- Latent Variables Capture Pathway-Level Points of Departure in High-Throughput Toxicogenomic Data.Chemical research in toxicology · 2022Article
- Comparison of pathway and gene-level models for cancer prognosis prediction.BMC bioinformatics · 2020Article
- PASNet: pathway-associated sparse deep neural network for prognosis prediction from high-throughput data.BMC bioinformatics · 2018Article
- Overlapping group screening for detection of gene-gene interactions: application to gene expression profiles with survival trait.BMC bioinformatics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Attempts to predict prognosis in cancer patients using high-dimensional genomic data such as gene expression in tumor tissue can be made difficult by the large number of features and the potential complexity of the relationship between features and the outcome. Integrating prior biological knowledge into risk prediction with such data by grouping genomic features into pathways and networks reduces the dimensionality of the problem and could improve prediction accuracy. Additionally, such knowledge-based models may be more biologically grounded and interpretable. Prediction could potentially be further improved by allowing for complex nonlinear pathway effects. The kernel machine framework has been proposed as an effective approach for modeling the nonlinear and interactive effects of genes in pathways for both censored and noncensored outcomes. When multiple pathways are under consideration, one may efficiently select informative pathways and aggregate their signals via multiple kernel learning (MKL), which has been proposed for prediction of noncensored outcomes. In this paper, we propose MKL methods for censored survival outcomes. We derive our approach for a general survival modeling framework with a convex objective function and illustrate its application under the Cox proportional hazards and semiparametric accelerated failure time models. Numerical studies demonstrate that the proposed MKL-based prediction methods work well in finite sample and can potentially outperform models constructed assuming linear effects or ignoring the group knowledge. The methods are illustrated with an application to 2 cancer data sets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.